Information:
Fel:
Nyckelord
Register ×
- COVID-19 (31)
- Lymphoma, Non-Hodgkin (30)
- Medical History Taking (25)
- Follow-Up Studies (21)
- Routine documentation (19)
- Neurology (17)
- Stroke (14)
- Cardiology (14)
- Neoplasms (14)
- Cardiovascular Diseases (13)
- Pediatrics (13)
- Sweden (12)
- Brain Injuries (12)
- Psychiatry (11)
- Bipolar Disorder (11)
- Documentation (11)
- Emergency Medical Services (11)
- Medical Oncology (11)
- Multiple Sclerosis (11)
- Myelodysplastic Syndromes (9)
- Breast Neoplasms (8)
- Leukemia (8)
- Ophthalmology (8)
- AML (7)
- Anemia, Sickle Cell (7)
- Quality of Life (6)
- Cerebral Palsy (6)
- Pandemics (6)
- Proposed Standard (6)
- GMDS-Challenge (6)
- Urology (5)
- Interview (5)
- Acute Coronary Syndrome (5)
- Emergency protocol (5)
- Health Services Research (5)
- Anesthesiology (5)
- Rehabilitation (4)
- Urinary Bladder Neoplasms (4)
- Critical Care (4)
- Glaucoma (4)
- Hematology (4)
- Mortality (4)
- Myocardial Infarction (4)
- Patient Admission (4)
- Physical Examination (3)
- Back Pain (3)
- Mammaplasty (3)
- Cardiopulmonary Resuscitation (3)
- Intensive Care (3)
- Disease Management (3)
- Physical Therapy Specialty (3)
- Stem Cell Transplantation (3)
- Cataract (3)
- CML (3)
- Adverse event (3)
- Registration (3)
- Baseline (3)
- Treatment Form (3)
- CLL (3)
- Eligibility Determination (3)
- Emergency Treatment (3)
- Patient Care (3)
- Craniocerebral Trauma (3)
- Lymphoma (3)
- Mastectomy (3)
- Postoperative Complications (2)
- Risk Factors (2)
- Scoliosis (2)
- General Surgery (2)
- Surgical Procedures, Operative (2)
- Therapeutics (2)
- Glasgow Coma Scale (2)
- Bone Marrow Transplantation (2)
- Caregivers (2)
- Neck Pain (2)
- Hormone Replacement Therapy (2)
- Vital Signs (2)
- Perioperative Period (2)
- Organ Dysfunction Scores (2)
- Patient Outcome Assessment (2)
- Visual Analog Scale (2)
- Response Evaluation Criteria in Solid Tumors (2)
- Common Data Elements (CDE) (2)
- Anticoagulation (2)
- Released Standard (2)
- Diagnosis (2)
- Disability Evaluation (2)
- Emergency Medicine (2)
- Epidemiology (2)
- Exercise Test (2)
- Family Planning Services (2)
- Alzheimer Disease (2)
- Geriatrics (2)
- Heart (2)
- Heart Failure (2)
- Anesthesia (2)
- Laboratories (2)
- Myeloproliferative Disorders (2)
- Nephrology (2)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
305 Sökresultat.
Item-grupper: Patient data, -, Therapeutic procedure , Tumor Status, Tumor Expansion
Item-grupper: Administrative data, Symptoms at initial diagnosis, Comorbidity at initial diagnosis, Comorbidity Follow up, Laboratory at initial diagnosis, Laboratory follow-up, Follow up, Disease progression, Blood cell morphology, Cellular Morphology Bone marrow, Histology Bone Marrow, Molecular Genetics, secondary myelodysplastic syndromes, Therapy Myelodysplastic syndrome, Treatment
Item-grupp: Patient registration
Eligibility
1 Item-grupp 5 DataelementVisit details
6 Item-grupper 29 DataelementBone marrow assessment
3 Item-grupper 13 DataelementConcomitant treatment
1 Item-grupp 5 DataelementWithdrawal
2 Item-grupper 7 DataelementGeneral medical history
1 Item-grupp 5 Dataelement Item-grupper: Signed informed consent available for participation in the registry and consultation, Signed informed consent available for data transfer, data storage, and data handling ..., Storage of remaining bio material with contact for each scientific usage, Storage and use of remaining bio material for the following research projects (pseudonymized) for all NHL, Storage and use of remaining bio material for the following research projects (pseudonymized) FOR LYMPHOBLASTIC LYMPHOMA, Storage and use of remaining bio material for the following research projects (pseudonymized) FOR MATURE B-CELL LYMPHOMA, Storage and use of remaining bio material for the following research projects (pseudonymized) FOR LARGE CELL ANAPLASTIC LYMPHOMA (ALCL)
Item-grupp: Thrombosis
Item-grupper: Registry Use Only, Identification Data, HSCT Type, Vital Status, Hematopoietic Reconstitution, Granulopoiesis / Neutrophil Recovery, Megakaryopoiesis / Platelet Recovery, Hematology findings, Immune Reconstitution, Chimerism analysis post transplantation, Chimerism Studies - Single Donor, Chimerism Studies - Multiple Donors, Engraftment Syndrome, Acute GVHD, Chronic GVHD, Infection, Pulmonary Function, Liver, Other Organ Impairment, New malignancy, Functional Status, Subsequent HSCT, Donor Cellular Infusion, Author Information
Item-grupper: CENTRE IDENTIFICATION, PATIENT DATA, DISEASE, HSCT, STEM CELLS (autograft or allograft), HSCT, AFTER HSCT, ADDITIONAL TREATMENT INCLUDING CELL THERAPY, DISEASE STATUS, Date of last follow up or death, DISEASE PRESENCE/DETECTION AT LAST CONTACT, PATIENT STATUS AT LAST CONTACT, COVER PAGE FOR HISTOCOMPATIBILITY REPORTS, HSCT - Minimum Essential Data - A First report - 100 days after HSCT - APPENDIX, DISEASE OF SECONDARY ORIGIN, THERAPY GIVEN PRIOR TO THIS HSCT, Comorbidity, HSCT - Minimum Essential Data - A First report - 100 days after HSCT - APPENDIX, HSCT - Minimum Essential Data - A First report - 100 days after HSCT - APPENDIX, HSCT - Minimum Essential Data - A First report - 100 days after HSCT DISEASE CLASSIFICATION SHEET 1
Item-grupper: Clinic information, Patient information
Item-grupper: Hospital Team, Patient, Disease, Initial Diagnosis, Cytgenetics, Molecular Biology, Involvement at Diagnosis, Type of HSCT, Treatment and Status of Disease at Stem Cell Collection, Status of Disease at HSCT, Additional Treatment Post-HSCT, Best disease response at 100 days post-HSCT, Forms to be filled in
Item-grupper: Patient information, Material, Sender information
Item-grupper: Patient information, Patient alive, death, recurrence
Item-grupp: Health Care Costs; health care financing